Black Swan Pharmaceuticals
Private Company
Total funding raised: $65M
Overview
Black Swan Pharmaceuticals is a private, commercial-stage Nigerian pharmaceutical services and distribution company. Contrary to the initial data suggesting a US-based RNA & Gene Therapy focus, the company's actual operations are centered on providing affordable generic medications, medical devices, diagnostic equipment, and laboratory analysis services in West Africa. Its business model is service and distribution-oriented, targeting institutional and governmental clients to improve healthcare accessibility in developing regions. The company appears to be revenue-generating through its product sales and service offerings.
Technology Platform
Integrated pharmaceutical and medical device supply chain, distribution network, and owned diagnostic service facilities (labs, imaging centers).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in the competitive Nigerian pharmaceutical distribution and medical supply market, competing against other indigenous distributors and multinational companies. Differentiates through an integrated model that includes owned diagnostic service facilities alongside product distribution.